Susquehanna International Group
PPH icon

Susquehanna International Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Susquehanna International Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Sell
26,600
-15,400
-37% -$1.64M ﹤0.01% 5438
2025
Q4 		$4.33M Buy
42,000
+8,100
+24% +$788K ﹤0.01% 4249
2025
Q3 		$3.06M Sell
33,900
-180,500
-84% -$15.8M ﹤0.01% 4941
2025
Q2 		$18.9M Sell
214,400
-114,500
-35% -$9.93M ﹤0.01% 2070
2025
Q1 		$30M Buy
328,900
+325,300
+9,036% +$29.3M 0.01% 1391
2024
Q4 		$311K Sell
3,600
-2,700
-43% -$244K ﹤0.01% 9762
2024
Q3 		$599K Sell
6,300
-1,600
-20% -$152K ﹤0.01% 8031
2024
Q2 		$723K Buy
7,900
+4,700
+147% +$420K ﹤0.01% 7342
2024
Q1 		$290K Buy
+3,200
New +$280K ﹤0.01% 9774
2023
Q3 		– Sell
-2,800
Closed -$221K – 12752
2023
Q2 		$221K Sell
2,800
-7,900
-74% -$618K ﹤0.01% 10082
2023
Q1 		$831K Buy
10,700
+8,100
+312% +$624K ﹤0.01% 7312
2022
Q4 		$202K Sell
2,600
-3,500
-57% -$258K ﹤0.01% 10098
2022
Q3 		$410K Sell
6,100
-4,700
-44% -$346K ﹤0.01% 9003
2022
Q2 		$830K Buy
10,800
+3,700
+52% +$289K ﹤0.01% 6990
2022
Q1 		$566K Sell
7,100
-7,300
-51% -$559K ﹤0.01% 8666
2021
Q4 		$1.11M Buy
14,400
+5,000
+53% +$372K ﹤0.01% 7032
2021
Q3 		$684K Buy
9,400
+2,900
+45% +$216K ﹤0.01% 8583
2021
Q2 		$475K Sell
6,500
-3,600
-36% -$257K ﹤0.01% 9720
2021
Q1 		$697K Buy
10,100
+300
+3% +$20.7K ﹤0.01% 8663
2020
Q4 		$651K Buy
+9,800
New +$628K ﹤0.01% 7704
2020
Q3 		– Sell
-18,000
Closed -$1.12M – 11013
2020
Q2 		$1.12M Sell
18,000
-4,100
-19% -$248K ﹤0.01% 5646
2020
Q1 		$1.2M Buy
22,100
+3,200
+17% +$197K ﹤0.01% 4967
2019
Q4 		$1.21M Buy
18,900
+4,800
+34% +$289K ﹤0.01% 5148
2019
Q3 		$802K Sell
14,100
-1,300
-8% -$74.5K ﹤0.01% 6187
2019
Q2 		$903K Buy
15,400
+7,600
+97% +$440K ﹤0.01% 5897
2019
Q1 		$473K Buy
+7,800
New +$461K ﹤0.01% 6392
2018
Q4 		– Sell
-16,200
Closed -$1.04M – 9756
2018
Q3 		$1.04M Buy
16,200
+600
+4% +$37.4K ﹤0.01% 5142
2018
Q2 		$920K Sell
15,600
-13,500
-46% -$782K ﹤0.01% 5531
2018
Q1 		$1.65M Buy
29,100
+23,400
+411% +$1.4M ﹤0.01% 4281
2017
Q4 		$339K Sell
5,700
-2,000
-26% -$115K ﹤0.01% 7377
2017
Q3 		$445K Buy
7,700
+2,400
+45% +$136K ﹤0.01% 6713
2017
Q2 		$313K Buy
+5,300
New +$300K ﹤0.01% 7522
2016
Q4 		– Sell
-3,700
Closed -$213K – 10017
2016
Q3 		$213K Buy
+3,700
New +$222K ﹤0.01% 7491
2016
Q2 		– Sell
-7,800
Closed -$448K – 9163
2016
Q1 		$448K Buy
+7,800
New +$461K ﹤0.01% 6594

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Susquehanna International Group's PPH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Pharmaceutical ETF (PPH) stake by 1,204% in Q1 2026, buying an estimated $8.28M and bringing the position to 84,211 shares worth $8.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Susquehanna International Group first reported a position in PPH in Q3 2013 and has held it in 40 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Susquehanna International Group held 84,211 shares of VanEck Pharmaceutical ETF worth $8.75M as of Q1 2026.
  • Susquehanna International Group bought 77,754 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $8.28M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3316 holding.
  • Susquehanna International Group first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 40 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.